Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-74,027
Closed -$18.8M 287
2020
Q3
$18.8M Sell
74,027
-41,424
-36% -$10.3M 0.2% 136
2020
Q2
$27.2M Sell
115,451
-12,466
-10% -$2.84M 0.25% 112
2020
Q1
$25.9M Buy
127,917
+120,158
+1,549% +$26.2M 0.23% 119
2019
Q4
$1.87M Sell
7,759
-63
-0.8% -$13.9K 0.01% 379
2019
Q3
$1.51M Sell
7,822
-75
-0.9% -$14.4K 0.01% 419
2019
Q2
$1.46M Sell
7,897
-14,233
-64% -$2.55M 0.01% 440
2019
Q1
$4.2M Sell
22,130
-2,577
-10% -$492K 0.02% 358
2018
Q4
$4.81M Sell
24,707
-18,000
-42% -$3.51M 0.03% 317
2018
Q3
$8.85M Sell
42,707
-24,632
-37% -$4.85M 0.04% 257
2018
Q2
$12.4M Sell
67,339
-4,168
-6% -$737K 0.06% 213
2018
Q1
$12.2M Buy
71,507
+41,628
+139% +$7.64M 0.06% 217
2017
Q4
$5.2M Buy
29,879
+1,643
+6% +$291K 0.02% 321
2017
Q3
$5.26M Sell
28,236
-129,101
-82% -$22.9M 0.02% 310
2017
Q2
$27.1M Sell
157,337
-1,122,960
-88% -$183M 0.12% 159
2017
Q1
$210M Sell
1,280,297
-115,773
-8% -$19.2M 0.87% 43
2016
Q4
$204M Sell
1,396,070
-78,476
-5% -$11.8M 0.84% 41
2016
Q3
$246M Buy
1,474,546
+5,528
+0.4% +$935K 1.05% 29
2016
Q2
$224M Buy
1,469,018
+208,153
+17% +$32.4M 0.99% 30
2016
Q1
$189M Buy
1,260,865
+918,405
+268% +$136M 0.82% 41
2015
Q4
$55.6M Buy
342,460
+178,911
+109% +$28.1M 0.24% 102
2015
Q3
$22.6M Buy
163,549
+109,699
+204% +$17.3M 0.1% 162
2015
Q2
$8.27M Buy
53,850
+47,950
+813% +$7.68M 0.04% 267
2015
Q1
$943K Sell
5,900
-12,000
-67% -$1.89M ﹤0.01% 405
2014
Q4
$2.85M Hold
17,900
0.01% 315
2014
Q3
$2.51M Sell
17,900
-35,410
-66% -$4.62M 0.01% 298
2014
Q2
$6.31M Sell
53,310
-1,835,692
-97% -$212M 0.03% 248
2014
Q1
$233M Sell
1,889,002
-123,808
-6% -$15M 1.02% 40
2013
Q4
$230M Sell
2,012,810
-112,130
-5% -$12.8M 1% 38
2013
Q3
$238M Sell
2,124,940
-15,040
-0.7% -$1.63M 1.08% 34
2013
Q2
$211M Buy
+2,139,980
New +$222M 0.98% 33

Other funds holding AMGN

AJO LP's AMGN Position: Q4 2020 in Review

AJO LP sold out of Amgen (AMGN) in Q4 2020, closing a stake of 74,027 shares — an estimated $18.8M sold.

AJO LP first reported a position in AMGN in Q2 2013 and held it in 30 quarters. The position peaked at $246M in Q3 2016. 2,218 funds tracked by Wall St. Rank hold AMGN as of Q4 2020.

  • AJO LP reported no remaining Amgen position as of Q4 2020 after selling out during the quarter.
  • AJO LP sold 74,027 Amgen shares in Q4 2020, an estimated $18.8M.
  • AJO LP first reported a position in Amgen in Q2 2013 and held it in 30 quarters.
  • AJO LP's Amgen position peaked at $246M in Q3 2016.
  • 2,218 funds tracked by Wall St. Rank held Amgen as of Q4 2020.

Based on AJO LP's 13F filing for Q4 2020, filed 5 Feb 2021.